Metyrapone

Metyrapone

SCHEMBL7020159

CC(C)(C(=O)c1cccnc1)c1cccnc1.c1ccc2ncccc2c1

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CYP11B1

The experimentally established mechanism targets of Metyrapone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 known ✓ P15538 1/20 0.74
LMNA P02545 1/20 0.74
CYP1A2 P05177 1/20 0.74
CYP3A4 P08684 1/20 0.74
CYP11B2 P19099 1/20 0.74
TDP1 Q9NUW8 1/20 0.74
SMN1; SMN2 Q16637 3/20 0.46
RAB9A P51151 3/20 0.46
NPC1 O15118 2/20 0.46
ALDH1A1 P00352 6/20 0.44
L3MBTL1 Q9Y468 1/20 0.41
KDM4E B2RXH2 2/20 0.40
THRB P10828 1/20 0.40
TP53 P04637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
HTT P42858 1/20 0.40
APP P05067 1/20 0.40
GAA P10253 1/20 0.40
HCAR3 P49019 1/20 0.40
HCAR2 Q8TDS4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Metyrapone SCHEMBL637432 0.86 TDP1 (1.00) LMNACYP1A2CYP3A4CYP11B1CYP11B2
Metyrapone SCHEMBL29462551 0.86 TDP1 (1.00) LMNACYP1A2CYP3A4CYP11B1CYP11B2
Metyrapone SCHEMBL29917903 0.86 TDP1 (1.00) LMNACYP1A2CYP3A4CYP11B1CYP11B2
Metyrapone SCHEMBL5484012 0.85 TDP1 (0.97) LMNACYP1A2CYP3A4CYP11B1CYP11B2
SCHEMBL12260655 0.82 CYP3A4 (0.84) LMNACYP1A2CYP3A4CYP11B1CYP11B2
Metyrapone SCHEMBL667560 0.77 LMNA (0.81) LMNACYP1A2CYP3A4CYP11B1CYP11B2
Metyrapone SCHEMBL667561 0.77 LMNA (0.81) LMNACYP1A2CYP3A4CYP11B1CYP11B2
Metyrapone SCHEMBL30807826 0.77 LMNA (0.81) LMNACYP1A2CYP3A4CYP11B1CYP11B2
SCHEMBL28905361 0.73 LMNA (0.68) LMNACYP1A2CYP3A4CYP11B1CYP11B2
SCHEMBL30176840 0.73 LMNA (0.68) LMNACYP1A2CYP3A4CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1351651-A2 MILD COSMETIC COMPOSITION WITH STABILIZED RETINOIDS UNILEVER PLC (GB) 2003-10-15 EP disclosed
EP-1349538-A2 SKIN CARE PRODUCT CONTAINING RETINOIDS, RETINOID BOOSTER AND PHYTOESTROGENS IN A DUAL COMPARTMENT PACKAGE UNILEVER PLC (GB) 2003-10-08 EP disclosed
EP-1349536-A2 STABLE SKIN CARE COMPOSITIONS CONTAINING A RETINOID AND A RETINOID BOOSTER SYSTEM UNILEVER PLC (GB) 2003-10-08 EP disclosed
EP-1345568-A2 STABLE SKIN CONDITIONING COMPOSITIONS CONTAINING RETINOID BOOSTERS UNILEVER PLC (GB) 2003-09-24 EP disclosed
EP-1345586-A2 STABLE SKIN CARE PRODUCT CONTAINING A RETINOID AND A RETINOID BOOSTER SYSTEM IN A DUAL COMPARTMENT PACKAGE UNILEVER PLC (GB) 2003-09-24 EP disclosed
WO-2002053125-A2 SKIN CARE PRODUCT CONTAINING A RETINOID AND A RETINOID BOOSTER SYSTEM IN A DUAL COMPARTMENT PACKAGE UNILEVER PLC (GB) 2002-07-11 WO disclosed
WO-2002053108-A2 SKIN CARE PRODUCT CONTAINING RETINOIDS, RETINOID BOOSTER AND PHYTOESTROGENS IN A DUAL COMPARTMENT PACKAGE UNILEVER PLC (GB) 2002-07-11 WO disclosed
WO-2002053123-A2 STABLE SKIN CARE PRODUCT CONTAINING A RETINOID AND A RETINOID BOOSTER SYSTEM IN A DUAL COMPARTMENT PACKAGE UNILEVER PLC (GB) 2002-07-11 WO disclosed
WO-2002053124-A2 STABLE SKIN CARE COMPOSITIONS CONTAINING A RETINOID AND A RETINOID BOOSTER SYSTEM UNILEVER PLC (GB) 2002-07-11 WO disclosed
WO-2002053089-A2 STABLE SKIN CONDITIONING COMPOSITIONS CONTAINING RETINOID BOOSTERS UNILEVER PLC (GB) 2002-07-11 WO disclosed
WO-2002041849-A2 MILD COSMETIC COMPOSITION WITH STABILIZED RETINOIDS UNILEVER PLC (GB) 2002-05-30 WO disclosed